- Markets
- ToolsPortfoliosTrack performance, allocation, dividends, and risksStock screenerFilter, compare, and track stocksInsiders tradingSee how executives tradeHistogramSee ratios across industriesSaved screenersMy highlights
- Sign in
- Sign up for free
- 1
- Portfolios
- Tools
- Stock screener
- Cryptocurrency screener
- Insiders trading
- SEC filings
- Bubbles
- Histogram
- Markets
Sign inSign up for free
Last updated: 20 June 2024 at 4:54pm EST
The estimated Net Worth of Stephen Michael Moore is at least $495 Thousand dollars as of 17 June 2024. Mr. Moore owns over 1,585 units of Personalis Inc stock worth over $411,032 and over the last 2 years he sold PSNL stock worth over $84,157. In addition, he makes $0 as General Counsel at Personalis Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Already have an account? Sign in
or
Sign up with GoogleSign up with Facebook
Mr. Moore PSNL stock SEC Form 4 insiders trading
Stephen has made over 13 trades of the Personalis Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 1,585 units of PSNL stock worth $2,045 on 17 June 2024.
The largest trade he's ever made was selling 5,733 units of Personalis Inc stock on 2 May 2022 worth over $31,703. On average, Stephen trades about 1,861 units every 46 days since 2022. As of 17 June 2024 he still owns at least 69,081 units of Personalis Inc stock.
You can see the complete history of Mr. Moore stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Already have an account? Sign in
or
Sign up with GoogleSign up with Facebook
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
StephenMoore biography
Stephen Moore serves as General Counsel of the Company. He joins Personalis after a decade at Pacific Biosciences (NASDAQ: PACB), where he served as General Counsel. Prior to Pacific Biosciences, Mr. Moore was General Counsel at Navigenics, a consumer genomics company that was later acquired by Life Technologies (now part of Thermo Fisher Scientific). Prior to Navigenics, he worked for over eight years at DNA microarray pioneer Affymetrix (which was also later acquired by Thermo Fisher Scientific), where he was most recently an Associate General Counsel. Mr. Moore holds a Bachelor of Arts degree in Political Science from San Jose State University, and a law degree from the University of California, Davis.
What's Stephen Moore's mailing address?
Stephen's mailing address filed with the SEC is C/O PERSONALIS, INC., 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555.
Insiders trading at Personalis Inc
Over the last 5 years, insiders at Personalis Inc have traded over $56,423,548 worth of Personalis Inc stock and bought 5,708,990 units worth $54,066,334. The most active insiders traders include Llp Abingworth, Paul Ricci, and Ai, Inc. Tempus.On average, Personalis Inc executives and independent directors trade stock every 15 days with the average trade being worth of $410,996. The most recent stock trade was executed by Ai, Inc. Tempus on 16 August 2024, trading 3,500,000 units of PSNL stock currently worth $17,745,000.
What does Personalis Inc do?
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
What does Personalis Inc's logo look like?
Complete history of Mr. Moore stock trades at Personalis Inc
Date | # Company | Insider | Trans. Transaction | Shares | Price per share | Total value | Shares after | Source |
---|---|---|---|---|---|---|---|---|
17 Jun 2024 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,585 | $1.29 | $2,045 17 Jun 2024 | 69,081 | ↗ |
17 May 2024 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,731 | $1.38 | $2,389 17 May 2024 | 70,666 | ↗ |
30 Apr 2024 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 4,523 | $1.37 | $6,197 30 Apr 2024 | 72,397 | ↗ |
15 Dec 2023 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,476 | $1.47 | $2,170 15 Dec 2023 | 76,920 | ↗ |
16 Nov 2023 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,722 | $1.04 | $1,791 16 Nov 2023 | 78,396 | ↗ |
16 Jun 2023 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,509 | $2.07 | $3,124 16 Jun 2023 | 80,118 | ↗ |
17 May 2023 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,781 | $1.98 | $3,526 17 May 2023 | 81,627 | ↗ |
2 May 2023 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 5,102 | $2.29 | $11,684 2 May 2023 | 83,408 | ↗ |
15 Dec 2022 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,930 | $2.50 | $4,825 15 Dec 2022 | 88,510 | ↗ |
16 Nov 2022 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 2,045 | $2.71 | $5,542 16 Nov 2022 | 90,440 | ↗ |
15 Jun 2022 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 1,832 | $3.24 | $5,936 15 Jun 2022 | 73,885 | ↗ |
16 May 2022 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 664 | $4.86 | $3,227 16 May 2022 | 75,717 | ↗ |
2 May 2022 | PSNLPersonalis Inc | Stephen Michael Moore SVP and Chief Legal Officer | Sale | 5,733 | $5.53 | $31,703 2 May 2022 | 76,381 | ↗ |
Personalis Inc executives and stock owners
Personalis Inc executives and other stock owners filed with the SEC include:
- AaronTachibana,
Chief Financial Officer - ClintonMusil,
Chief Business Officer - John Stephen West,
Co-Founder, CEO, Pres & Director - PaulRicci,
Independent Director - JohnWest,
President, Chief Executive Officer, Director - Dr. Richard Chen M.D., M.S., MS,
Sr. VP of R&D and Chief Medical Officer - RichardChen,
Chief Science Officer - Aaron L. Tachibana,
Sr. VP & CFO - Dr. Richard Chen M.S., M.D., MS,
Chief Scientific Officer - A. BlaineBowman,
Independent Director - AlanColowick,
Independent Director - KarinEastham,
Independent Director - JonathanMacQuitty,
Independent Chairman of the Board - KennethLudlum,
Independent Director - PatrickBalthrop,
Independent Director - StephenMoore,
General Counsel - Dr. Euan A. Ashley DPHIL, FRCP, M.D., Ph.D.,
Co-Founder and Member of Clinical & Scientific Advisory Board - Prof. Russ B. Altman M.D., Ph.D.,
Co-Founder and Member of Clinical & Scientific Advisory Board - Michael J. Fitzpatrick,
VP of Worldwide Sales - Stephen M. Moore J.D.,
VP, Gen. Counsel & Corp. Sec. - Carol J. Tillis,
VP of Fin. & Admin. - Dr. Michael Snyder Ph.D.,
Co-Founder and Member of Clinical & Scientific Advisory Board - Dr. Atul Butte,
Co-Founder and Member of Clinical & Scientific Advisory Board - Dr. Euan A. Ashley M.D., Ph.D., FRCP, DPHIL,
Co-Founder and Member of Clinical & Scientific Advisory Board - Prof. Russ B. Altman,
Co-Founder and Member of Clinical & Scientific Advisory Board - Kenneth J Widder,
- Olivia Kyusuk Bloom,
- Ken Ludlum,
Director - Mdv Partners, L.L.C.Mdv Ix ...,
- Venture Partners Viii Lp Li...,
- Venture Partners Select Iv,...,
- Llp Abingworth,
- Christopher M Hall,
PRESIDENT AND CEO - Venture Partners Select Iv,...,
- Ai, Inc. Tempus,
10% owner - Lonnie Shoff,
"A killer stock screener."
— Berry M., Switzerland
Give wallmine a try – it's free.